Streetbeat News

Stock Prices

CCOEY

DSNKY

EWJ

HMC

NMR

NSANY

SONY

UBS AG is reinstating its equity strategist role for Japan, indicating a growing interest in Japanese equities. JP Morgan also sees potential in the market. The iShares MSCI Japan Index Fund (EWJ) provides exposure to this market. BlackRock identifies Japan as a beneficiary of global fragmentation and notes the outperformance of companies with low price-to-book ratios. Stocks with low P/B ratios like Nissan (NSANY), Honda (HMC), and Nomura (NMR) have shown strong returns, while those with high P/B ratios like Capcom (CCOEY), Daiichi Sankyo (DSNKY), and Sony (SONY) have mixed performance.

Portfolio Pulse from Surbhi Jain

December 20, 2023 | 1:38 pm

TTC

Toro's stock (TTC) is trading higher following the release of their Q4 financial results, which surpassed expectations. Additionally, the company has provided guidance that is influencing market sentiment.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:36 pm

NVEI

Barclays analyst John Coffey has initiated coverage on payment technology company Nuvei (NASDAQ:NVEI) with an Overweight rating and set a price target of $34. This new coverage could influence investor sentiment and potentially affect the stock's performance in the short term.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:36 pm

FDX

FedEx Corp (NYSE:FDX) stock fell after reporting Q2 revenue and EPS below estimates, with revenue at $22.2 billion against estimates of $22.39 billion, and EPS at $3.99 versus $4.19 expected. Despite lower revenue, operating income increased, attributed to the company's DRIVE program. FedEx expects a low-single-digit percentage decline in full-year 2024 revenue and forecasts earnings of $17 to $18.50 per share, below the $18.25 estimate. Analysts at JPMorgan and Barclays lowered their price targets for FedEx following the results.

Portfolio Pulse from Adam Eckert

December 20, 2023 | 1:34 pm

TTC

Toro (NYSE:TTC) reported Q4 adjusted EPS of $0.71, surpassing the $0.56 estimate, and sales of $983.20M, exceeding the $973.65M estimate. However, these figures represent a 36.04% decrease in earnings and a 16.11% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:32 pm

BCAB

CRDF

CYAN

XAIR

Insiders at four healthcare-related penny stocks have made notable purchases. Cyanotech Corporation's director acquired 400,000 shares for $400,000 after a narrower Q2 loss. BioAtla, Inc.'s director bought 20,000 shares for $41,048 despite a Q3 net loss increase. Beyond Air, Inc. saw a director purchase 1.2 million shares for $1.96 million, and the CEO and Chairman also bought shares, following downbeat quarterly results. Cardiff Oncology, Inc.'s director acquired 30,000 shares for $41,100 after posting upbeat quarterly results.

Portfolio Pulse from Avi Kapoor

December 20, 2023 | 1:31 pm

GIS

General Mills' stock (GIS) is trading lower following the release of mixed Q2 financial results and an update to its full-year guidance. The company's performance did not align with market expectations, leading to a negative reaction in its stock price.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:31 pm

CLDX

ESPR

MGNX

VRCA

Four health care stocks are showing signs of being overbought according to their Relative Strength Index (RSI) values, which may indicate a potential short-term pullback. Esperion Therapeutics (ESPR), Celldex Therapeutics (CLDX), Verrica Pharmaceuticals (VRCA), and MacroGenics (MGNX) have all seen significant price increases recently, with their RSI values exceeding the typical overbought threshold of 70. This suggests that these stocks may experience a downturn in the near future as traders who rely on momentum indicators might consider taking profits.

Portfolio Pulse from Avi Kapoor

December 20, 2023 | 1:31 pm

SPY

The USA Current Account for Q3 reported a deficit of $200.3 billion, slightly better than the estimated deficit of $197.0 billion and an improvement from the previous quarter's deficit of $216.8 billion.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:31 pm

ACON

FDX

Aclarion, Inc. (NASDAQ:ACON) shares surged by approximately 53% in pre-market trading due to the grant of a U.S. patent for an MR spectroscopy system to diagnose intervertebral discs related to severe low back pain. Other stocks experienced significant movement in pre-market trading, with various gainers and losers listed, including AEye, Inc. (NASDAQ:LIDR), Applied UV, Inc. (NASDAQ:AUVI), and FedEx Corporation (NYSE:FDX), which saw a pre-market decline after reporting weaker-than-expected earnings and lowering its full-year revenue outlook.

Portfolio Pulse from Avi Kapoor

December 20, 2023 | 1:31 pm